|
|
| |
|
|
| |
 |
Fang Hu, M.D. , Ph.D. |
Fang Hu was born and raised in the city Kunming, P.R. China. She earned her medical degree from the Kunming Medical College and her Ph. D. degree from Peking Union Medical College, the number one ranked medical college in China. Her thesis focused on specializing in research of signaling transduction pathway of the Human Tumor Necrosis Factor alpha (hTNFα) and derivatives in vitro and in vivo, She conducted some insightful and valuable research on the signaling cascades in vivo activated by hTNFα, and its further influence on cellular cycle involved in molecular mechanism of hTNFα and its derivation. She also researched the development and evaluation of Hepatitis C Virus multi-epitopes antigen as a candidate vaccine. Her advanced level training in the sciences at Harbor-UCLA brought her to explore the development of brain angiotensin systems and osmoregulatory systems during the fetal periods in utero. The functional developments of brain angiotensin and osmoregulatory mechanisms are critical to both prenatal and postnatal life and impacts significantly adult health and adult diseases. The multidisciplinary training in medical and biomedical fields exposed her to the mind-body dichotomy in the context of chronic diseases.
She continued her career as a postdoctoral research fellow at Emory University School of Medicine starting in 2004. Her research project is positioned at the interface of basic and clinical research, and is designed to identify candidate signaling pathways that contribute to the altered glucocorticoid receptor (GR) function that has been observed in major depression as well as other medical conditions. She has published over 20 research papers in international / national scientific conferences and journals both here in the U.S. and abroad. She has received numerous awards during her career. |
|
| |
|
|
|
